Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Citigroup Inc.
Another Reason To Consider Bank ETFs
UPDATE: Citigroup Reiterates Buy Rating, Raises PT for Linn Energy
UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for Walgreen
UPDATE: Citigroup Reiterates Buy Rating, Raises PT for Linn Energy
UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for Walgreen
UPDATE: Citigroup Reiterates Buy/High Risk Rating, Raises PT for Cheniere Energy
Citigroup Reiterates Buy Rating, $81 PT for ACE Limited
UPDATE: Citigroup Reiterates Buy/High Risk Rating, Raises PT for Cheniere Energy
Citigroup Reiterates Buy Rating, $81 PT for ACE Limited
UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT for Cooper Companies
UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT for The Cooper Companies
Read More...
Citigroup Inc. Recent News
Citigroup Reiterates Buy Rating, $35 PT for Microsoft
Citigroup Reiterates Buy Rating, $129 PT for Medivation
UPDATE: Citigroup Reiterates Buy Rating, Raises PT for Dollar General
UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for DTE Energy
UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT for Golar LNG
UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT for BlackRock
Citigroup Reiterates Sell Rating, $26 PT for Quality Systems
UPDATE: Citigroup Maintains Buy Rating, Lowers PT for Avago Technologies
UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for St. Jude Medical
UPDATE: Citigroup Maintains Buy Rating, Lowers PT for Medtronic
UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for Boston Scientific
UPDATE: Citigroup Reiterates Buy Rating, Raises PT for hiSoft Technology
UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for DigitalGlobe
Citigroup Maintains Buy Rating, $85 PT for Watson Pharmaceuticals
UPDATE: Citigroup Maintains Buy Rating, Raises PT for KBR
UPDATE: Citigroup Reiterates Buy Rating, Raises PT for KLA-Tencor
UPDATE: Citigroup Maintains Neutral Rating, Raises PT for Baker Hughes
UPDATE: Citigroup Reiterates Neutral Rating, Raises PT for Total System Services
UPDATE: Citigroup Reiterates Buy Rating, $37 PT for Mattel
Study: Citigroup Stock Not Affected By U.S. Treasury Sales
Citigroup Ups Price Target on Aegon
Jeffries & Company Issues Opinion On "Truth in Lending Act"
Citigroup (C) Long Term Profits "Not Really A Concern"